Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$348.81M
Gross Margin
99.32%
TTM Avg
95.85%
3Y Avg
93.96%
5Y Avg
99.79%
Market Cap
$344.82M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$353.82M
Gross Margin
98.15%
TTM Avg
96.49%
3Y Avg
98.25%
5Y Avg
98.83%
Market Cap
$354.03M
Gross Margin
57.21%
TTM Avg
58.46%
3Y Avg
59.89%
5Y Avg
60.54%
Market Cap
$359.88M
Gross Margin
93.73%
TTM Avg
92.44%
3Y Avg
93.34%
5Y Avg
78.89%
Market Cap
$359.28M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
75.00%
5Y Avg
66.67%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | $346.88M | 0.00% | 0.00% | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $348.81M | 99.32% | 95.85% | 93.96% | 99.79% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| Embecta Corp. (EMBC)vs › | $349.74M | 59.89% | 63.90% | 65.83% | 67.05% |
| Ocugen, Inc. (OCGN)vs › | $353.49M | 45.86% | 48.66% | 71.42% | -2398.51% |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.82M | 98.15% | 96.49% | 98.25% | 98.83% |
| Viemed Healthcare, Inc. (VMD)vs › | $354.03M | 57.21% | 58.46% | 59.89% | 60.54% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.88M | 93.73% | 92.44% | 93.34% | 78.89% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $359.28M | 0.00% | 50.00% | 75.00% | 66.67% |
| Opus Genetics, Inc. (IRD)vs › | $361.26M | 99.87% | 100.00% | 100.00% | 83.33% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2024-06-30 | 0.00% |
